Lipid-lowering drugs save lives, but use decreasing medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Sweden: Early monomorphic ventricular tachycardia (VT) compared to nonmonomorphic VT/VF (ventricular fibrillation) is associated with a higher risk of all-cause mortality in STEMI patients, concludes.
Patient-Level VHA Data Show No Association Between Paclitaxel-Coated Devices and Long-Term Mortality
Created with Sketch.
February 23, 2021 In the first study examining the impact of paclitaxel-coated device (PCD) use on mortality in patients treated within the Veterans Health Administration (VHA), Gutierrez et al found no increased risk of long-term all-cause mortality associated with PCD use. The study was recently published in the
KEY FINDINGS
The rates of 2- and 3-year all-cause mortality were similar between the PCD and non-PCD groups, even when stratified by claudication or critical limb ischemia presentations.
No statistically significant risk in all-cause mortality was seen between the use of PCD and non-PCD devices after adjustment for treatment assignment.